Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |